Expression and distribution of ‘high affinity’ glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system
Open Access
- 30 October 2008
- journal article
- Published by Wiley in Journal of Anatomy
- Vol. 213 (5) , 539-546
Abstract
L‐Glutamate is one of the major excitatory neurotransmitters in the mammalian central nervous system, but recently it has been shown to have a role also in the transduction of sensory input at the periphery, and in particular in the nociceptive pathway. An excess of glutamate is implicated in cases of peripheral neuropathies as well. Conventional therapeutic approaches for treating these diseases have focused on blocking glutamate receptors with small molecules or on reducing its synthesis of the receptors through the inhibition of glutamate carboxypeptidase II (GCPII), the enzyme that generates glutamate.In vivostudies have demonstrated that the pharmacological inhibition of GCPII can either prevent or treat the peripheral nerve changes in both BB/Wor and chemically induced diabetes in rats. In this study, we characterized the expression and distribution of glutamate transporters GLT1, GLAST, EAAC1 and of the enzyme GCPII in the peripheral nervous system of female Wistar rats. Immunoblotting results demonstrated that all glutamate transporters and GCPII are present in dorsal root ganglia (DRG) and the sciatic nerve. Immunofluorescence localization studies revealed that both DRG and sciatic nerves were immunopositive for all glutamate transporters and for GCPII. In DRG, satellite cells were positive for GLT1 and GCPII, whereas sensory neurons were positive for EAAC1. GLAST was localized in both neurons and satellite cells. In the sciatic nerve, GLT1 and GCPII were expressed in the cytoplasm of Schwann cells, whereas GLAST and EAAC1 stained the myelin layer. Our results give for the first time a complete characterization of the glutamate transporter system in the peripheral nervous system. Therefore, they are important both for understanding glutamatergic signalling in the PNS and for establishing new strategies to treat peripheral neuropathies.Keywords
This publication has 45 references indexed in Scilit:
- Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: Role of glutamate uptake and FK506 binding protein 12 kDaNeuroscience, 2006
- Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injuryJournal of Neurochemistry, 2005
- The central nervous system effects, pharmacokinetics and safety of the NAALADase‐inhibitor GPI 5693British Journal of Clinical Pharmacology, 2005
- Nociception in vertebrates: key receptors participating in spinal mechanisms of chronic pain in animalsBrain Research Reviews, 2004
- Cellular localization of three vesicular glutamate transporter mRNAs and proteins in rat spinal cord and dorsal root gangliaSynapse, 2003
- Glutamate and aspartate immunoreactivity in dorsal root ganglion cells supplying visceral and somatic targets and evidence for peripheral axonal transportJournal of Comparative Neurology, 2000
- Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosisAnnals of Neurology, 1998
- Expression of high-affinity neuronal and glial glutamate transporters in the rat optic nerveGlia, 1997
- NMDA receptor antagonists: interactions with opioidsActa Anaesthesiologica Scandinavica, 1997
- Involvement of increased excitatory amino acids and intracellular Ca2+ concentration in the spinal dorsal horn in an animal model of neuropathic painPain, 1996